AMZN
Amazon.com, Inc.
AMZN has the edge over JD overall, supported by stronger valuation and stronger fundamentals.
JD
JD.com, Inc.
JD's outlook is improving, though it still trails on the overall score.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
JD Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Strong |
JD's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over JD in the historical PE scenario, which offers more potential upside but is not a forecast.
JD PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $14.79 | -46% |
| Fair | 15x | $23.37 | -15% |
| Current | 18x | $27.49 | — |
| Expensive | 30x | $45.14 | +64% |
Historical ranges are pointers, not guarantees.
JD's PE is 18x, but its earnings don't support one, so it isn't a reliable read right now.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
JD Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for JD, with profitability improving. However, they disagree widely on these estimates.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over JD on earnings, with more consistent year-over-year improvement.
JD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $1.52 | -60% |
| Q1 2026 | $1.39 | -69% |
| Q4 2025 | $1.94 | -52% |
| Q3 2025 | $3.18 | -6.2% |
| Q2 2025 | $3.83 | +29% |
| Q1 2025 | $4.44 | +87% |
| Q4 2024 | $4.05 | +77% |
| Q3 2024 | $3.39 | +51% |
JD's earnings per share have fallen from their peak: $1.52 over the past year, against $4.95 in early 2021.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over JD on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over JD on profitability, with a higher operating margin.
JD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $51.8B | -3.2% |
| Q1 2026 | $47.1B | +4.2% |
| Q4 2025 | $52.9B | +1.5% |
| Q3 2025 | $44.9B | +15% |
| Q2 2025 | $53.5B | +22% |
| Q1 2025 | $45.2B | +16% |
| Q4 2024 | $52.1B | +13% |
| Q3 2024 | $39.1B | +5.1% |
JD's revenue has held roughly level: $51.8B last quarter, down 3.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 1.2% | +1.4 points |
| Q1 2026 | 1.2% | -2.3 points |
| Q4 2025 | -1.7% | -4.1 points |
| Q3 2025 | -0.3% | -5 points |
| Q2 2025 | -0.2% | -3.8 points |
| Q1 2025 | 3.5% | +0.5 points |
| Q4 2024 | 2.5% | +1.8 points |
| Q3 2024 | 4.6% | +0.9 points |
JD's operating margin was 1.2% last quarter, up 1.4 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
JD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $4.8B | +49% |
| Q1 2026 | -$676.5M | +$2.4B |
| Q4 2025 | $2.2B | -23% |
| Q3 2025 | -$1.6B | +$142M |
| Q2 2025 | $3.2B | -55% |
| Q1 2025 | -$3.1B | -$959M |
| Q4 2024 | $2.8B | +73% |
| Q3 2024 | -$1.7B | -216% |
JD has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
JD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.7% | -24.5M shares |
| 1 year | -5.2% | -77M shares |
| 3 years | -11% | -175M shares |
| 5 years | -12% | -187M shares |
| Available history | -5.2% | -77.6M shares |
JD has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $3.2B |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $3.9B |
| Q3 2024 | — |
JD spent $3.2B buying back its own shares over the past year, down 17% from the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
JD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | -0.2x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.2x | Net Cash |
| Q4 2024 | -0.4x | Net Cash |
| Q3 2024 | -0.3x | Net Cash |
JD has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
JD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.0 | Neutral |
| Stochastic | 28.1 | Neutral |
JD's weekly RSI is 48 (neutral) and its Stochastic is 28 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
JD PE vs Consumer Cyclical Sector
| Metric | JD | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 59 | 47 | 12 pts above |
JD has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over JD on trend strength, trading above more of its moving averages.
JD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $26.8 | 2.8% above |
| 20 week MA | $28.2 | 2.5% below |
| 50 week MA | $28.6 | 3.8% below |
| 100 week MA | $31.7 | 13% below |
| 200 week MA | $32.4 | 15% below |
JD has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 15% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over JD on returns for 2026, with the stronger performance.
JD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.9 | $84.5 | +135% |
| 2021 | $84.5 | $68.7 | -19% |
| 2022 | $68.7 | $56.4 | -18% |
| 2023 | $56.4 | $28.9 | -49% |
| 2024 | $28.9 | $35.0 | +21% |
| 2025 | $35.0 | $29.4 | -16% |
| 2026 YTD | $29.4 | $27.5 | -6.5% |
JD's yearly returns have swung widely, from +135% in 2020 to −49% in 2023. It's down 6.5% so far in 2026.